China Resources Pharmaceutical Group Limited (HKG:3320)
6.38
-0.12 (-1.85%)
Apr 17, 2026, 4:08 PM HKT
HKG:3320 Market Cap
HKG:3320 has a market cap or net worth of 40.08 billion as of April 17, 2026. Its market cap has increased by 15.58% in one year.
Market Cap
40.08B
Enterprise Value
176.52B
Revenue
299.99B
Ranking
n/a
PE Ratio
8.91
Stock Price
6.38
Market Cap Chart
Since October 28, 2016, HKG:3320's market cap has decreased from 55.61B to 40.08B, a decrease of -27.93%. That is a compound annual growth rate of -3.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 40.08B | 43.37% |
| Dec 31, 2025 | 27.96B | -21.93% |
| Dec 31, 2024 | 35.81B | 11.11% |
| Dec 29, 2023 | 32.23B | -18.83% |
| Dec 30, 2022 | 39.71B | 78.03% |
| Dec 31, 2021 | 22.30B | -10.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simcere Pharmaceutical Group | 35.62B |
| China Medical System Holdings | 33.72B |
| Sunshine Lake Pharma | 25.36B |
| Grand Pharmaceutical Group | 23.67B |
| The United Laboratories International Holdings | 19.81B |
| Fujian Haixi Pharmaceuticals | 15.36B |
| CanSino Biologics | 14.08B |
| Consun Pharmaceutical Group | 13.73B |